Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diksha Kaushik

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
AAPS Pharmscitech|June 29, 2010
Percutaneous penetration modifiers and formulation effects: thermal and spectral analysesDiksha Kaushik, Bozena Michniak-Kohn
International Journal of Pharmaceutics|November 11, 2009
Percutaneous penetration modifiers and formulation effectsDiksha Kaushik, Aurora Costache, Bozena Michniak-Kohn
Clinical Biochemistry|March 31, 2023
Validation and application of volumetric absorptive microsampling (VAMS) dried blood method for phenylalanine measurement in patients with phenylketonuriaLan Gao, Neil Smith, Diksha Kaushik, et al.
Journal of Nanoscience and Nanotechnology|December 4, 2008
Study of self-organized CdS Q-dotsDiksha Kaushik, Madhulika Sharma, A B Sharma, et al.
Bioanalysis|December 15, 2023
LC-MS/MS methods for direct measurement of sepiapterin and tetrahydrobiopterin in human plasma and clinical applicationsDiksha Kaushik, Lan Gao, Kun Yuan, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese ParticipantsLan Gao, Diksha Kaushik, Kimberly Ingalls, et al.
Expert Opinion on Drug Delivery|May 22, 2008
Percutaneous permeation modifiers: enhancement versus retardationDiksha Kaushik, Priya Batheja, Brian Kilfoyle, et al.
Clinical Pharmacology in Drug Development|August 12, 2024
Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of VatiquinoneLucy Lee, Martin Thoolen, Jiyuan Ma, et al.
Drugs in R&D|September 24, 2024
Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy VolunteersLan Gao, Diksha Kaushik, Kimberly Ingalls, et al.
Bioanalysis|October 16, 2020
LC-MS/MS quantification of ataluren and ataluren acyl glucuronide in human plasma/urine: application in clinical studiesDiksha Kaushik, Jiyuan Ma, Guodong Gu, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
AAPS Pharmscitech|June 29, 2010
Percutaneous penetration modifiers and formulation effects: thermal and spectral analysesDiksha Kaushik, Bozena Michniak-Kohn
International Journal of Pharmaceutics|November 11, 2009
Percutaneous penetration modifiers and formulation effectsDiksha Kaushik, Aurora Costache, Bozena Michniak-Kohn
Clinical Biochemistry|March 31, 2023
Validation and application of volumetric absorptive microsampling (VAMS) dried blood method for phenylalanine measurement in patients with phenylketonuriaLan Gao, Neil Smith, Diksha Kaushik, et al.
Journal of Nanoscience and Nanotechnology|December 4, 2008
Study of self-organized CdS Q-dotsDiksha Kaushik, Madhulika Sharma, A B Sharma, et al.
Bioanalysis|December 15, 2023
LC-MS/MS methods for direct measurement of sepiapterin and tetrahydrobiopterin in human plasma and clinical applicationsDiksha Kaushik, Lan Gao, Kun Yuan, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese ParticipantsLan Gao, Diksha Kaushik, Kimberly Ingalls, et al.
Expert Opinion on Drug Delivery|May 22, 2008
Percutaneous permeation modifiers: enhancement versus retardationDiksha Kaushik, Priya Batheja, Brian Kilfoyle, et al.
Clinical Pharmacology in Drug Development|August 12, 2024
Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of VatiquinoneLucy Lee, Martin Thoolen, Jiyuan Ma, et al.
Drugs in R&D|September 24, 2024
Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy VolunteersLan Gao, Diksha Kaushik, Kimberly Ingalls, et al.
Bioanalysis|October 16, 2020
LC-MS/MS quantification of ataluren and ataluren acyl glucuronide in human plasma/urine: application in clinical studiesDiksha Kaushik, Jiyuan Ma, Guodong Gu, et al.
Pageof 3